Bioanalytical Systems to Release Second Quarter Fiscal 2014 Results on Thursday May 15, 2014; Conference Call & Webcast Set for 11:00 a.m. EDT
GlobeNewswire - Mon May 05, 8:42AM CDT
Bioanalytical Systems, Inc. (Nasdaq:BASI) will release financial results for the second quarter of fiscal 2014 ended March 31, 2014 at approximately 8:30 a.m. EDT on Thursday, May 15, 2014. BASi has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter. To participate in the call, dial 866.713.8563, passcode #24051454.
BASi Reports First Quarter Results
Business Wire - Thu Feb 13, 7:00AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the first quarter of fiscal 2014.
Bioanalytical Systems to Release First Quarter Fiscal 2014 Results on Thursday, February 13, 2014; Conference Call & Webcast Set for 11:00 a.m. EST
GlobeNewswire - Wed Feb 05, 7:00AM CST
Bioanalytical Systems, Inc. (Nasdaq:BASI) will release financial results for the first quarter of fiscal 2014 ended December 31, 2013 at approximately 8:30 a.m. EST on Thursday, February 13, 2014. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 800 299.9630, passcode #66359984.
Bioanalytical Systems, Inc. to Present at the 10th Annual Noble Financial Capital Markets Equity Conference Wednesday, January 22, 2014 at 10:00 a.m. EST
Business Wire - Tue Jan 14, 11:31AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will make a presentation at the Tenth Annual Noble Financial Capital Markets Equity Conference on Wednesday, January 22, 2014 at 10:00 a.m. EST in Room 1 at the Club Med in Sandpiper Bay, Florida.
Nasdaq stocks posting largest volume increases
AP - Tue Dec 24, 4:53PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
BASi Reports Profitable Fourth Quarter and Fiscal 2013
Business Wire - Tue Dec 24, 6:30AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the fourth quarter and fiscal 2013, highlighted by net income of $252,000, or $0.03 per diluted share, for the fourth quarter and $773,000, or $0.09 per diluted share, for the year. This compares to net losses of $2,696,000, or $0.36 per share and $6,317,000, or $0.88 per share, for the fourth quarter and fiscal 2012.
Bioanalytical Systems Reschedules Fourth Quarter & Fiscal 2013 Earnings Release to Tuesday, December 24, 2013; Conference Call & Webcast Set For 11:00 a.m. EST
Business Wire - Thu Dec 19, 6:00AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) has rescheduled the release of financial results for the fourth quarter and fiscal 2013 ended September 30, 2013 to Tuesday, December 24, 2013. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 866.825.1709, passcode #95235310.
Bioanalytical Systems to Release Fourth Quarter & Fiscal 2013 Results on Thursday, December 19, 2013; Conference Call & Webcast Set for 11:00 a.m. EST
GlobeNewswire - Thu Dec 12, 11:09AM CST
Bioanalytical Systems, Inc. (Nasdaq:BASI) will release financial results for the fourth quarter and fiscal 2013 ended September 30, 2013 at approximately 8:30 a.m. EST on Thursday December 19, 2013. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 866.825.1709, passcode #95235310.
BASi Files Form 8K Notice of Non-Compliance with a Continued Listing Rule Non-Reliance on Previously Issued Financial Statements
Business Wire - Wed Aug 21, 5:00PM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that on August 15, 2013, the Company received a letter from the Nasdaq Listing Qualifications Department stating that the Company no longer complies with the Listing Rules for continued listing of the Company's common shares on the Nasdaq Capital Market since the Company has not yet filed its Form 10-Q for the period ended June 30, 2013 with the Securities and Exchange Commission.
BASi Files Form 12b-25
Business Wire - Wed Aug 14, 8:00AM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it is unable to file its Form 10-Q for the three and nine months ended June 30, 2013, as it works to resolve a complex accounting issue relating to the accounting treatment for its outstanding warrants. As a result, the announcement of BASi's third quarter and nine month financial results and the conference call scheduled for today have been postponed.
Bioanalytical Systems to Release Third Quarter Results Wednesday, August 14, 2013; Conference Call & Webcast Set for 11:00 a.m. EDT
GlobeNewswire - Wed Aug 07, 7:30AM CDT
Bioanalytical Systems, Inc. (Nasdaq:BASI) will release financial results for the third quarter ended June 30, 2013 at approximately 8:30 a.m. EDT on Wednesday, August 14, 2013. BASi has scheduled a conference call at 11:00 a.m. EDT that morning to discuss its results for the quarter. To participate in the call, dial 877.415.3178, passcode #76846443.
BASi Reports Second Quarter Results
Business Wire - Wed May 15, 7:30AM CDT
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the second quarter and first half of fiscal 2013.
BASi Launches Innovative Glucose Monitoring Project With Pinnacle Technology
Business Wire - Thu May 02, 7:30AM CDT
BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) announced today that it is collaborating with Pinnacle Technology Inc. in proof-of-concept studies combining BASi's Culex(R) NxT automated blood sampling system with Pinnacle's glucose sensor to create an innovative new option for high quality data collection for diabetes and other glucose research.
Zacks Rank #1 Addition for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 18, 7:44AM CDT
Here are 5 stocks added to the Zacks Rank #1 ("strong buy"
WEALTHMAKERS.COM Issues Bullish Research Reports on AIZ, AME, AZK, BASI, BKJ, BWS
M2 - Fri Mar 15, 10:50AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Assurant Inc (NYSE:AIZ), Ametek Inc (NYSE:AME), AURIZON MINES LTD (AMEX:AZK), Bioanalytical Systems Inc (NASDAQ:BASI), Bank of New Jersey Inc (AMEX:BKJ), Brown Shoe Co Inc (NYSE:BWS)
WEALTHMAKERS.COM Issues Bullish Research Reports on BASI, CADX, CODI, CPA, GCO, ISLE
M2 - Fri Mar 15, 3:11AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Bioanalytical Systems Inc (NASDAQ:BASI), Cadence Pharmaceuticals Inc (NASDAQ:CADX), Compass Diversified Holdings (NYSE:CODI), Copa Holdings SA (NYSE:CPA), Genesco Inc (NYSE:GCO), Isle of Capri Casinos Inc (NASDAQ:ISLE)
BASi Reports First Quarter Net Income of $0.02 Per Share versus a Prior Year First Quarter Net Loss of $0.21 Per Share
Business Wire - Thu Feb 14, 7:30AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) today announced financial results for the first quarter ended December 31, 2012.
Jacqueline Lemke Named President and CEO of BASi
Business Wire - Tue Feb 12, 7:30AM CST
BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) announced today that Jacqueline Lemke has been named President and CEO, with continuing responsibility as CFO. Ms. Lemke also has been appointed to BASi's Board of Directors. She had served as Interim President and CEO since July 2012, and was named CFO in April 2012.
Bioanalytical Systems to Release First Quarter Results Thursday, February 14, 2013
Business Wire - Mon Feb 04, 7:30AM CST
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the first quarter ended December 31, 2012 at approximately 8:30 a.m. EST on Thursday, February 14, 2013. BASi has scheduled a conference call at 11:00 a.m. EST that morning to discuss its results for the quarter. To participate in the call, dial 866.356.4441, passcode #56594205.